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The Effects of Cognitive Training Program for Cognitively Impaired 
Older Adults: A Pilot Randomized Control Trial
Objective: This pilot investigation evaluated the effectiveness 
of a cognitive training program for older adults with cognitive im-
pairment.
Methods: A sample of 23 individuals were randomly assigned 
to either a 24-session cognitive training program or a wait-list 
control group. Cognitive training sessions required participants to 
complete activities that targeted the following cognitive domains: 
attention, visual and verbal memory, visual spatial skills, pro-
cessing speed, executive functioning, and language.  A battery of 
cognitive tests were administered prior to and immediately after 
completion of the program.  Depression, quality of life, agitated 
behavior, and daily functioning were also assessed.  
Results: Small to large effect sizes on half of the cognitive out-
come measures were observed following participation in the pro-
gram. No positive effects were found with regard to non-cognitive 
outcomes.
Discussion: These results warrant further investigation into the 
benefits of this cognitive training program in larger randomized 
control trials.
Clinical Implications: The cognitive training program may pro-
vide activity staff in assisted living or memory care settings a 
highly structured, manualized, and user-friendly intervention for 
older adults experiencing cognitive decline. 
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Declines in certain cognitive abilities such as
processing speed and some forms of memory
are relatively normal in older adulthood,
although these declines typically do not
negatively affect daily functioning.1 For some
older adults, however, declines in cognitive
functioning progress to the point where
completing day-to-day activities independently
becomes difficult or dangerous.  In fact, over 46
million individuals worldwide live with dementia
and estimates are these numbers could rise to
over 131 million by 2050.2
Although medications are available that can
slow the progression of cognitive decline, the
effects are generally temporary and may not be
clinically meaningful.3 Consequently,
professionals have investigated the possible
benefits of non-pharmacological approaches for
slowing cognitive decline and enhancing quality
of life.  One such approach is cognitive training,
which uses guided practice on a set of
standardized tasks to target and improve
specific cognitive functions such as memory or
language. 4
Most cognitive training programs are designed
to prevent cognitive decline in older adults not
yet experiencing significant cognitive
impairment.  However, a small body of literature
has examined the possible benefits of cognitive
training for persons already experiencing
cognitive decline.  This literature has produced
highly variable results.  For example, some
studies have found positive effects on various
cognitive abilities.5-7 In addition, a review of 19
studies found large effects on measures of
verbal memory .8
Conversely, a review of 11 randomized control
trials found that cognitive training was not
associated with positive or negative effects on
any outcome measures.4  Another meta-analysis
of 19 studies concluded effect sizes were
negligible to low on cognitive and functional
outcome measures and the majority of studies
were of low to moderate scientific quality.9  In
addition, even when benefits occurred, there
was no evidence that benefits transferred to 
untrained tasks or everyday situations.   
The purpose of the current pilot study was to 
explore the efficacy and feasibility of a cognitive 
training program for individuals with cognitive 
impairment of moderate severity.  The study was 
intended to add to the small number of 
randomized control studies in this area.  
Because findings in the existing literature have 
varied widely across studies, no specific 
hypotheses were asserted regarding the 
benefits of the training program and all analyses 
were exploratory in nature.  
Method 
Settings and Participants 
Participants were recruited from four facilities in 
a small metropolitan area in the Midwestern 
United States. Three were assisted living 
facilities with memory care units, while the fourth 
was a health care facility that provided assisted 
care for older nuns.  
Recruitment involved asking facility staff to 
identify residents diagnosed with a 
neurocognitive disorder or who otherwise 
displayed signs of cognitive impairment.  After 
consent forms approved by the Institutional 
Review Board were signed by legal guardians, 
individuals were administered the Modified Mini-
Mental Status Examination (3MS).10  
Participants who scored in the “moderate 
impairment” range (between 77-48) were 
included in the study, as this is the population for 
which the cognitive training program was 
designed.  The mean 3MS score was 66.7 (SD 
= 8.94).   
Exclusion criteria included a 3MS score outside 
the 77-48 range or the presence of significant 
visual, hearing, or motor impairments that could 
prevent successful participation in the program.  
The presence of a neurocognitive disorder was 
not required for inclusion, nor was the absence 
of a neurocognitive disorder an exclusion 
criterion.  This was the case because staff 
observed that many individuals were 
experiencing genuine cognitive decline, but 
IJOAR: http://escipub.com/international-journal-of-aging-research/                       3
Jeffrey A. Buchanan et al., IJOAR, 2019 2:30
never received formal diagnosis of
neurocognitive disorder. Therefore, diagnostic
status appeared to be an imperfect indicator of
the severity of cognitive impairment and
appropriateness for the program.
Twenty-three individuals participated in the
study.  All participants were Caucasian, and
included twenty-two females and one male
ranging in age from 64 to 97 (M = 86.3; SD =
7.22).  Thirteen participants obtained a four-year
degree or higher while the remaining ten
participants obtained a high school diploma.
Fourteen individuals had a neurocognitive
disorder (n = 7 in both the treatment and control
groups) and thirteen of them took medications
for their condition.  The dosages of all
medications remained unchanged throughout
the study.  All participants completed at least
75% of the classes (range = 75-100%, M =
92.1%).
Materials 
The cognitive training program used in this study 
was designed to be appropriate for adults with 
moderate cognitive impairment.  A master trainer 
from the organization that developed the 
program trained activity staff to deliver the 
program and provided them with a detailed 
treatment manual.  The program included 24, 
one-hour classes delivered 2-3 times a week 
over an 8-12 week period.  Classes comprised 
of 3-5 individuals and included a sequence of 
activities related to six cognitive domains: 
reaction time, attention, visuospatial skills, short-
term verbal memory, language, and problem 
solving.  Activities took approximately 5-12 
minutes and gradually increased in difficulty as 
the program progressed. 
 
 
Table 1 Outcome Measures 
Cognitive Domain Instrument 
Global Cognitive Ability 
 
Attention 
Modified Mini-Mental State Examination (3MS)10 
 
Forward & Backward Digit Span14 
Brief Test of Attention15  
 
Visual Memory: 
Immediate recall,  
delayed recall, and  
recognition memory 
 
Brief Visuospatial Memory Test – Revised16 
 
Verbal Memory: 
Immediate recall,  
delayed recall, and  
recognition memory 
 
Hopkins Verbal Learning Test17 
 
Visual Spatial Skills Clock Drawing Test18 
 
Processing Speed 
 
Executive Functioning 
 
Trail Making Test Part A19 
 
Trail Making Test Part B19 
Language 
 
Depression 
 
Quality of Life 
 
Agitated Behavior 
 
Daily Functioning 
 
Controlled Oral Word Association Test20 
 
Patient Health Questionnaire-9 Observer Version21  
 
QUALIDEM22  
 
Cohen-Mansfield Agitation Inventory23  
 
Functional Status measure from Minimum Data Set 3.024 
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Research Design and Procedure
Participants were randomly assigned to either
the cognitive training program (n = 11) or a
waitlist control group (n = 12).  Within one week
prior to starting the program, the researchers
administered a battery of neuropsychological
tests assessing the six cognitive domains
targeted by the program.  In addition, nursing
staff who knew participants for at least three
months completed measures of emotional,
behavioral, social and daily functioning.  All
outcome measures were repeated within one
week upon completion of the program (see
Table 1).
Results
Due to the small sample size, a single Cohen’s 
d effect size (ES) was calculated for all outcome 
measures to determine the clinical magnitude of 
the intervention.  ES was calculated in the 
following way: the numerator of the formula was 
calculated by subtracting the difference between 
pre-treatment and post-treatment means for the 
control group from the pre-treatment to post-
treatment difference for the experimental group.  
The denominator of the formula was the average 
of the standard deviations for the control group 
and experimental group at pre-treatment.11 
According to Cohen,12 an ES of .2 is small, .5 is 
medium, and .8 is large.   
 
Table 2 Effect Size for All Outcome Measures 
Domain Cohen's d 
General Cognitive Functioning (3MS) 0.28* 
 
Simple Attention (Digits forward) 0.03 
 
Divided Attention/Working Memory (Digits backward) 1.33*** 
 
Divided Attention (BTA) -0.07 
 
Immediate Verbal Recall (HVLT) 0.38* 
 
Delayed Verbal Recall (HVLT) -0.19 
 
Verbal Recognition (HVLT) 0.15 
 
Immediate Visual Recall (BVMT-R) 0.48** 
 
Delayed Visual Recall (BVMT-R) -0.13 
 
Visual Recognition (BVMT-R) 0.38* 
 
Language/Executive Functioning (COWAT) -0.22 
 
Visual-Spatial (Clock Drawing) -0.21 
 
Perceptual Speed (TMT-A) 1.14*** 
 
Executive Functioning (TMT-B) 1.10*** 
 
Depression 0.07                                      
 
Quality of Life -0.23 
 
Daily Functioning 0.21 
 
Agitated Behavior -0.29 
*Small treatment effect  **Medium treatment effect ***Large treatment effect 
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As can be seen in Table 2, the intervention group
showed superior functioning at post-treatment
on measures of seven cognitive domains:
general cognitive functioning (small ES), divided
attention/working memory (large ES), immediate
recall for verbal material (small ES), immediate
memory of visual material (medium ES),
recognition of visual material (small ES),
perceptual speed (large ES), and cognitive
flexibility/executive functioning (large ES).
There were no group differences on measures
of five cognitive domains (i.e., simple attention,
divided attention, recognition of verbal material,
and delayed recall of verbal and visual material).
Small effect sizes favoring the control group
were found on measures of language and
visuospatial skills.  On measures of agitated
behavior, quality of life or daily functioning, the
treatment group actually showed small declines
(i.e., inferior performance) compared to the
control group, while there were no group
differences with regard to depressive symptoms.
Discussion
Although the study produced mixed findings, the
results showed some benefits associated with a
comprehensive cognitive training program for
individuals with moderate cognitive impairment.
Seven of fourteen cognitive domains showed
some improvement when comparing treatment
and control groups.  These differences include
small effects in general cognitive functioning,
immediate verbal recall, and visual recognition;
a medium effect on immediate visual recall; and
large effects on complex attention, processing
speed, and executive functioning.  These
findings are consistent with previous studies
showing individuals with cognitive impairment
can improve in processing speed,6 verbal
learning,8 overall cognitive functioning ,7 and
working memory.5
Other results were consistent with findings from
meta-analyses that suggest cognitive training
does not benefit persons with cognitive
impairment.4,9 For example, negligible effect
sizes were found on measures of five cognitive
domains and the measures of language and
visual-spatial skills showed declines.  Finally, 
measures of depressive symptoms, frequency of 
behavioral problems, daily functioning, and 
quality of life showed no improvements.  These 
results are consistent with previous research 
suggesting that even when cognitive functioning 
improves, benefits do not necessarily generalize 
to everyday functioning.9   
Follow-up interviews revealed that the program 
was well received among staff.  Staff reportedly 
found the classes easy to administer and 
incorporate into their normal activity schedule, 
and classes required minimal (<10 min) 
preparation and clean up time.  Staff also 
reported that most residents enjoyed the classes 
and no adverse events occurred.   
Limitations and Future Directions 
Although the study produced some encouraging 
results, there were several important limitations.  
First, the sample was small and homogenous 
with regard to gender and ethnicity.  Conversely, 
the sample was heterogeneous with regard to 
the presence of preexisting medical and 
psychiatric conditions.  Although individuals 
diagnosed with neurocognitive disorders were 
equally distributed between groups, these 
individuals would be expected to show a 
different rate of cognitive decline over time 
compared to individuals with no diagnosis, thus 
making it more difficult to establish the effects of 
the cognitive training program beyond natural 
rates of cognitive decline.  Moreover, those with 
no diagnosis of neurocognitive disorder showed 
moderate cognitive impairment on the 3MS, 
raising the possibly that they actually had some 
form of neurocognitive disorder, but had not 
been formally diagnosed.  Future studies would 
benefit from larger and more demographically 
diverse samples, more homogenous samples in 
terms of preexisting diagnoses of neurocognitive 
disorder, and matching participants in 
experimental conditions with regard to the 
severity of pre-treatment cognitive functioning.   
Because this was a field study, there was a lack 
of control over certain elements of the study.  For 
example, due to scheduling conflicts, the 
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number of classes offered each week varied
both within and across facilities.  In addition,
although detailed treatment manuals were
provided to class facilitators, it is unclear how
reliably the classes were implemented.
Therefore, it will be important to measure
treatment adherence in order to ensure
consistent administration of the program over
time and across sites.
Future research should adhere to more
consistent testing schedules than were
implemented in this study.  For example, testing
was conducted on two different days to prevent
fatigue, and although testing sessions typically
occurred on consecutive days, this was not
always possible.  In addition, testing did not
always occur at the same time of day due to
unpredictable schedules of participants and
researchers.  Given that cognitive functioning in
older adults tends to deteriorate as the day
continues,13 these inconsistencies in the timing
of assessment could have produced unwanted
variability in test scores.
Finally, in order to more definitively determine if
the program is responsible for change, future
studies should incorporate active control
conditions (e.g., completing arts and crafts) that
involve social and cognitive stimulation, but do
not include activities that systematically target
specific cognitive functions as was done in the
cognitive training program.
Clinical Implications
• Activity staff in assisted living facilities and
memory care units are often looking to
develop novel and effective programming to
address cognitive decline in their residents.
• The cognitive training program evaluated for
this study may represent a viable form of
alternative programming for promoting
cognitive health in older adults who are
experiencing cognitive decline.
• The program evaluated in this study is highly
structured, manualized, comprehensive, and
user-friendly for both participants as well as
class facilitators.
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